Information from Ovide website at www.ovide.us
Ovide® (malathion) Lotion, 0.5% is FDA-approved as a first line head lice treatment. Clinical studies have shown that Ovide® (malathion) Lotion kills head lice and their nits. There are no documented reports that U.S. head lice in the U.S. are resistant to Ovide® (malathion) Lotion, 0.5%.
Minor side effects observed in trials of malathion lotion, 0.5%, include a temporary increase in dandruff in those prone to this condition. Irritation to the skin and scalp is the most common adverse reaction.
Accidental contact with the eyes can result in mild conjunctivitis. OVIDE Lotion is contraindicated for neonates and infants. Because this product contains alcohol, it is flammable. Keep away from heat sources (i.e., hair dryers, cigarettes) or open flame while hair is wet. Please see accompanying full prescribing information.
Ovide® is a registered trademark of Taro Pharmaceuticals U.S.A., Inc.